Calendar

Short Course 3: Mechanistic PKPD to Overcome Translational Considerations...

Catherine Abbott — Tue, 21 May 2013 14:05:01 GMT

Short Course 3: Mechanistic PKPD to Overcome Translational Considerations... 2013-11-10 8:00 AM 2013-11-10 4:30 PM Mechanistic PKPD to Overcome Translational Considerations for Antibody Drug Conjugates (ADC) and THIOMABs (TDCS)—Nonclinical to First in Human and Beyond The aim of this short

Short Course 6: Accelerating Global Product Registration

Catherine Abbott — Mon, 20 May 2013 19:46:29 GMT

Short Course 6: Accelerating Global Product Registration 2013-11-10 8:00 AM 2013-11-10 4:30 PM This short course will bring together regulatory and industry experts to examine similarities and differences of stability requirements of different regions and discuss the possibility of harmonizing

Short Course 5: Drug Repositioning in the Postgenomic Era

Catherine Abbott — Mon, 20 May 2013 19:45:29 GMT

Short Course 5: Drug Repositioning in the Postgenomic Era 2013-11-10 8:00 AM 2013-11-10 4:30 PM This short course will update our knowledge and recent progress in drug repositioning and discuss the future directions of this important approach for drug discovery. AAPS Meeting Henry B. Gon

Short Course 4: Technology Transfer and Integration for Pharmaceutical and Biotech Industry

Catherine Abbott — Mon, 20 May 2013 19:45:08 GMT

Short Course 4: Technology Transfer and Integration for Pharmaceutical and Biotech Industry 2013-11-10 8:00 AM 2013-11-10 4:30 PM This course is designed to cover a range of transfer and integration challenges ranging from a single project to a large portfolio. Throughout the short course, ex

Short Course 2: Quality Control of Nanoparticulate Drugs

Catherine Abbott — Mon, 20 May 2013 19:32:27 GMT

Short Course 2: Quality Control of Nanoparticulate Drugs: Manufacturing, Characterization and Regulatory Considerations 2013-11-10 8:00 AM 2013-11-10 4:30 PM There have been significant advances in the development and application of nanoparticle technologies in drug formulation and delivery. W

Short Course 1: Drug Development and Discovery by FDA Standards

Catherine Abbott — Mon, 20 May 2013 17:25:37 GMT

Short Course 1: Drug Development and Discovery by FDA Standards 2013-11-10 8:00 AM 2013-11-10 4:30 PM The course is designed to be useful to scientists who are working in small and large pharmaceutical industry and academia who are interested in understanding better the process of drug develop

Webinar: Skin Microdialysis for Dermatokinetics of Therapeutics

Catherine Abbott — Mon, 20 May 2013 17:02:53 GMT

Webinar: Skin Microdialysis for Dermatokinetics of Therapeutics 2013-09-12 12:30 PM 2013-09-12 2:00 PM Grazia Stagni, Ph.D., and Mandip Sachdeva, Ph.D. Long Island University and Florida A&M University This webinar will discuss the basics of microdialysis, the advances in the technology, tro

Webinar: The Role of Transporters on Unbound Intracellular Concentrations

Catherine Abbott — Mon, 20 May 2013 17:01:38 GMT

Webinar: The Role of Transporters on Unbound Intracellular Concentrations 2013-09-19 12:30 PM 2013-09-19 2:00 PM Ken Korzekwa, Ph.D., and Sid Bhoopathy, Ph.D. Temple University and Absorption Systems This presentation will summarize practical considerations for in vitro and computational models

Webinar: Strategies towards Assessment of Prodrugs as a Means of Improving PK of Promising Potential Drug Candidates

Catherine Abbott — Thu, 16 May 2013 17:15:42 GMT

Webinar: Strategies towards Assessment of Prodrugs as a Means of Improving PK of Promising Potential Drug Candidates 2013-09-05 12:30 PM 2013-09-05 2:00 PM Sophie-Dorothee Clas, Ph.D. and Dave Dubost, Ph.D. Merck & Co., Inc. If the benefit of a prodrug need is recognized early, then it can b

2nd Zagreb International Conference on Pharmaceutical Sciences

Catherine Abbott — Thu, 16 May 2013 17:10:55 GMT

2nd Zagreb International Conference on Pharmaceutical Sciences 2013-10-25 2013-10-26 Sharing a Vision Toward Better and Safe Medicines—The objective of this conference is to strengthen and broaden the international network which advances and supports the paradigm of the safety sciences by sh

CRS Workshop on Introduction to Microencapsulation Technologies

Catherine Abbott — Mon, 13 May 2013 18:54:09 GMT

Introduction to Microencapsulation Technologies 2013-11-10 2013-11-10 Knowledge of multiple encapsulation technologies and how they are applied is valuable information for developing new products or solving existing problems. It is important, at a minimum, to have a basic understanding of al

CRS Workshop on Mitigating Risks for Patients When Developing Oral Controlled Release Dosage Forms

Catherine Abbott — Mon, 13 May 2013 18:53:50 GMT

Mitigating Risks for Patients When Developing Oral Controlled Release Dosage Forms 2013-11-09 2013-11-10 The focus will be to understand the possible risks to patients and approaches to manage them when developing oral extended-release (ER) dosage forms. The discussion will relate to the des

Webinar: DeNovo Expression of OATP1B3 in Prostate Tumor Cells

Catherine Abbott — Wed, 01 May 2013 19:49:37 GMT

Webinar: DeNovo Expression of OATP1B3 in Prostate Tumor Cells: Implications on Androgen Deprivation Therapy 2013-08-08 12:30 PM 2013-08-08 2:00 PM Tristan M. Sissung, Ph.D., M.S. National Cancer Institute Industry and academic participants involved in the role of transporters in oncology and dis

Webinar: Application of Rotating Disk Dissolution to Pharmaceutical Development

Catherine Abbott — Wed, 01 May 2013 19:41:20 GMT

Webinar: Application of Rotating Disk Dissolution to Pharmaceutical Development 2013-08-01 12:30 PM 2013-08-01 2:00 PM Michael Hawley Boehringer-Ingelheim We will discuss the use of the rotating disk dissolution (intrinsic dissolution) technique in pharmaceutical development. Rotating disk disso

Webinar: Understanding the Gastrointestinal Drug and Dosage Form Processes Controlling Absorption: I.GI Physiology

Catherine Abbott — Wed, 01 May 2013 19:37:20 GMT

Webinar: Understanding the Gastrointestinal Drug and Dosage Form Processes Controlling Absorption: I.GI Physiology 2013-07-25 12:30 PM 2013-07-25 2:00 PM Steev Sutton University of New England The GI Physiology webinar is a primer on the anatomy and physiology of the gastrointestinal (GI) tract.

Webinar: Commonly seen CMC Deficiencies in the Abbreviated New Drug Applications (ANDAs)

Catherine Abbott — Wed, 01 May 2013 19:28:15 GMT

Webinar: Commonly seen CMC Deficiencies in the Abbreviated New Drug Applications (ANDAs) 2013-06-25 12:30 PM 2013-06-25 2:00 PM Robert Iser U.S. Food and Drug Administration This webinar will focus on the commonly seen deficiencies in the abbreviated new drug applications (ANDAs), specifically i

Webinar: Selection of API Starting Materials: Technical and Regulatory Considerations

Catherine Abbott — Wed, 01 May 2013 19:24:32 GMT

Webinar: Selection of API Starting Materials: Technical and Regulatory Considerations 2013-07-11 12:00 PM 2013-07-11 1:00 PM Ron Ogilvie, Ph.D. Pfizer Inc. Selection of active pharmaceutical ingredient (API), i.e., drug substance, starting materials for commercial manufacture requires the spons

Webinar: On the Shelf Life of Pharmaceutical Products

Catherine Abbott — Wed, 01 May 2013 16:51:17 GMT

Webinar: On the Shelf Life of Pharmaceutical Products 2013-06-20 12:30 PM 2013-06-20 2:00 PM James Schwenke, Ph.D. and Pat Forenzo Applied Research Consultants and Novartis Pharmaceuticals This webinar proposes new terminology that distinguishes between different concepts involved in the discuss

American Association of Bangladeshi Pharmaceutical Scientists (AABPS), 2013

Catherine Abbott — Tue, 16 Apr 2013 15:48:40 GMT

American Association of Bangladeshi Pharmaceutical Scientists (AABPS), 2013 2013-06-08 9:00 AM 2013-06-08 10:00 PM The Executive Committee is delighted to invite you to attend the AABPS Meeting. Meeting Objectives: • Establish a strong professional network • Generate and share membership ar

CALBIO13: Success Redefined

Catherine Abbott — Tue, 30 Apr 2013 16:00:06 GMT

CALBIO13: Success Redefined 2013-06-12 2013-06-14 California. The birthplace of the biotechnology industry and home to the largest and most productive concentration of life science companies in the world. Over the years, our focus has remained constant—discover the next great thing and turn